The U.S. Food and Drug Administration (FDA) issued final guidance for people who wish to comment during the agency’s advisory committee meetings. The FDA “encourages participation from all stakeholders in its decision-making process. Every advisory committee meeting includes an open public hearing session, during which interested people may present relevant information or their oral and/or written views. The guidance finalizes information contained in the 2005 draft guidance titled The Open Public Hearing – FDA Advisory Committee Meetings – Draft Guidance.”

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm236245.htm